Key result
Invasive management in older patients with NSTE-ACS reduces the risk of non-fatal myocardial infarction and repeat revascularisation, though it may not improve mortality.
Why the study?
Deciding which patients are most likely to benefit from an invasive approach in the older population with NSTE-ACS remains a key challenge.
Does invasive management reduce mortality, non-fatal myocardial infarction, or repeat revascularisation compared to conservative management in older patients with NSTE-ACS?
Does invasive management reduce mortality, non-fatal myocardial infarction, or repeat revascularisation compared to conservative management in older patients with NSTE-ACS?
Invasive management in older patients with NSTE-ACS reduces non-fatal MI and repeat revascularization but may not improve mortality, highlighting the need for individualized decision-making.
INTRODUCTION: Invasive management of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) should be considered regardless of age, but a key challenge is deciding which patients are most likely to benefit from an invasive approach in the older population. In addition to assessment of the clinical signs and symptoms, a holistic assessment of geriatric syndromes such as frailty, multimorbidity and cognitive impairment is of increasing importance. Recent trials have validated the roles of physiological assessment and intracoronary imaging to guide revascularisation. AREAS COVERED: This review focuses on the comparison between invasive and conservative management in the older population with NSTE-ACS, the clinical characteristics of the older population with NSTE-ACS, and the role of physiological assessment and intracoronary imaging to guide revascularisation in this cohort. EXPERT OPINION: Invasive management in the older population with NSTE-ACS may not improve mortality but reduces the risk of non-fatal myocardial infarction and repeat revascularisation. Decisions surrounding invasive versus conservative management should be individualized to each patient, depending on patient preference, clinical features, comorbidities and frailty. In patients where invasive management is indicated, a combination of physiological assessment and intracoronary imaging is likely to improve revascularisation outcomes, especially in the context of complex anatomical characteristics like multivessel disease.
No takes yet. Share an insight, caveat, or question.
Gill et al. (2025) conducted a review in non-ST-segment elevation acute coronary syndrome (NSTE-ACS). Invasive management vs. Conservative management was evaluated. Invasive management in older patients with NSTE-ACS reduces the risk of non-fatal myocardial infarction and repeat revascularisation, though it may not improve mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: